BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2012
View Archived Issues
Studies yield encouraging VRS-317 pharmacodynamic and safety data
Read More
Pfizer immunotherapeutic for inflammatory diseases shows promise in phase I trials
Read More
Epicutaneous patch for peanut allergy safe and effective in patients
Read More
Michael J. Fox Foundation extends support to biomarker research program
Read More
Insmed doses first patient in TARGET-NTM trial
Read More
Investigators in Israel design new mouse model of familial dysautonomia
Read More
Vorinostat in combination with bortezomib: Final results from VANTAGE trials
Read More
FDA approves Astellas drug for overactive bladder
Read More
Anthera updates phase III blisibimod plans
Read More
Gilead submits NDA for elvitegravir
Read More
Merrimack adds third arm to phase III trial in metastatic pancreatic cancer
Read More
FDA grants priority review to NDA for regorafenib
Read More
Novel PARP inhibitors developed in China
Read More
New formylpeptide receptor ligands patented by Allergan
Read More
Lilly presents novel MAP kinase p38 inhibitors
Read More
Research at Pfizer yields novel potential antibacterial drugs
Read More
New notum-directed antibodies may be useful to treat osteoporosis
Read More
Novel potential cancer immunotherapy designed in Korea
Read More
Synta reports on interim analysis of GALAXY trial
Read More
FDA accepts Shionogi NDA for review
Read More
Sanwa and Fuji submit application for hyperuricemia and gout treatment in Japan
Read More
Compugen shows potential of another B7/CD28-like protein target
Read More
SymBio opens enrollment in Japanese rigosertib trial
Read More
Astellas' Gonax approved in Japan
Read More
Vertex Pharmaceuticals announces final phase II data on VX-809/Kalydeco combination
Read More
Oxis Turbuhaler approved in Japan in different formulations
Read More
Eisai and Toyama Chemical obtain approval in Japan for rheumatoid arthritis drug
Read More
Japanese authorities approve Inlyta tablets
Read More
Mitsubishi Tanabe drug approved for type 2 diabetes
Read More